734 related articles for article (PubMed ID: 17252575)
21. Positron-emission tomography for head and neck cancer.
Greven KM
Semin Radiat Oncol; 2004 Apr; 14(2):121-9. PubMed ID: 15095258
[TBL] [Abstract][Full Text] [Related]
22. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Majhail NS; Urbain JL; Albani JM; Kanvinde MH; Rice TW; Novick AC; Mekhail TM; Olencki TE; Elson P; Bukowski RM
J Clin Oncol; 2003 Nov; 21(21):3995-4000. PubMed ID: 14581422
[TBL] [Abstract][Full Text] [Related]
23. Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI.
Ruf J; Lopez Hänninen E; Oettle H; Plotkin M; Pelzer U; Stroszczynski C; Felix R; Amthauer H
Pancreatology; 2005; 5(2-3):266-72. PubMed ID: 15855825
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
25. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
Erzen D; Sencar M; Novak J
J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353
[TBL] [Abstract][Full Text] [Related]
26. Imaging of non-central nervous system primitive neuroectodermal tumours: diagnostic features and correlation with outcome.
Dick EA; McHugh K; Kimber C; Michalski A
Clin Radiol; 2001 Mar; 56(3):206-15. PubMed ID: 11247698
[TBL] [Abstract][Full Text] [Related]
27. [
Metser U; Kulanthaivelu R; Salawu A; Razak A; Mak V; Li X; Langer DL; MacCrostie P; Singnurkar A
J Nucl Med; 2023 Sep; 64(9):1371-1377. PubMed ID: 37414444
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
[TBL] [Abstract][Full Text] [Related]
29. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
Even-Sapir E
J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
[TBL] [Abstract][Full Text] [Related]
30. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.
Gayed I; Vu T; Johnson M; Macapinlac H; Podoloff D
Mol Imaging Biol; 2003; 5(1):26-31. PubMed ID: 14499159
[TBL] [Abstract][Full Text] [Related]
31. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
33. The role of positron emission tomography (PET) in the management of cervical lymph nodes metastases from an unknown primary tumour.
Mevio E; Gorini E; Sbrocca M; Artesi L; Mullace M; Caimi F
Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):342-7. PubMed ID: 15952684
[TBL] [Abstract][Full Text] [Related]
34. Cross-sectional imaging in non-melanoma skin cancer of the head and neck.
Lanka B; Turner M; Orton C; Carrington BM
Clin Radiol; 2005 Aug; 60(8):869-77. PubMed ID: 16039922
[TBL] [Abstract][Full Text] [Related]
35. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
[TBL] [Abstract][Full Text] [Related]
36. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
Eubank WB; Mankoff DA; Schmiedl UP; Winter TC; Fisher ER; Olshen AB; Graham MM; Eary JF
AJR Am J Roentgenol; 1998 Oct; 171(4):1103-10. PubMed ID: 9763005
[TBL] [Abstract][Full Text] [Related]
37. [Computerized tomography and magnetic resonance in the diagnosis of recurrent rectal neoplasms: comparison of reliability and errors of both methods].
Golfieri R; Totaro C; Giampalma E; Lalli A; Sbrozzi F; Soro A; Nogara G; Gavelli G
Radiol Med; 1996 May; 91(5):601-9. PubMed ID: 8693127
[TBL] [Abstract][Full Text] [Related]
38. Advantages and limitations of FDG PET in the follow-up of breast cancer.
Lind P; Igerc I; Beyer T; Reinprecht P; Hausegger K
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S125-34. PubMed ID: 15085295
[TBL] [Abstract][Full Text] [Related]
39. [Sarcoma of the pulmonary artery--pre- and postoperative radiologic findings in initial tumor manifestation and recurrence].
Fasse A; Kauczor HU; Mayer E; Kreitner KF; Heussel CP; Thelen M
Rofo; 1999 Jan; 170(1):112-8. PubMed ID: 10071656
[TBL] [Abstract][Full Text] [Related]
40. Update on gastrointestinal imaging.
Koslin DB
Rev Gastroenterol Disord; 2002; 2(1):3-10. PubMed ID: 12122977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
